Alie Wurie

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Alie Wurie, Lihua Hou et al. · The Lancet · 2016 · 198 citations

Vaccination, Vaccine Safety, Vaccine Development +6

Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study

Marta Lado, Naomi F. Walker, Peter Baker et al. · The Lancet Infectious Diseases · 2015 · 115 citations

Retrospective Cohort Study, Virus Epidemiology, Clinical Epidemiology +9

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +9

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 85 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +10

Epidemiology of Ebola virus disease transmission among health care workers in Sierra Leone, May to December 2014: a retrospective descriptive study

Olushayo Oluseun Olu, Brima Kargbo, Sarian Kamara et al. · BMC Infectious Diseases · 2015 · 66 citations · Full text